1. Home
  2. LQDT vs REPL Comparison

LQDT vs REPL Comparison

Compare LQDT & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

SELL

Current Price

$43.88

Market Cap

1.4B

ML Signal

SELL

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

SELL

Current Price

$10.82

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LQDT
REPL
Founded
1999
2015
Country
United States
United States
Employees
818
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
LQDT
REPL
Price
$43.88
$10.82
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
★ $51.00
$19.50
AVG Volume (30 Days)
225.2K
★ 1.8M
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.10
N/A
EPS
★ 0.78
N/A
Revenue
★ $476,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$497.81
P/E Ratio
$56.53
★ N/A
Revenue Growth
★ 31.20
N/A
52 Week Low
$21.67
$1.50
52 Week High
$45.00
$16.33

Technical Indicators

Market Signals
Indicator
LQDT
REPL
Relative Strength Index (RSI) 56.40 32.47
Support Level $36.82 $6.81
Resistance Level $44.23 $11.05
Average True Range (ATR) 1.16 0.71
MACD 0.07 -0.20
Stochastic Oscillator 68.97 1.83

Price Performance

Historical Comparison
LQDT
REPL

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Share on Social Networks: